ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Safety, Tolerability, and Effectiveness of CGP77116 in Patients With Multiple Sclerosis (MS)

This study has been completed.
Information provided by National Institutes of Health Clinical Center (CC)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001781


Locations
United States, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)





Links to all studies - primarily for crawlers